Benefit-Risk Assessment Based on Ordered Clinical Outcomes

被引：0
|
作者：
Caster, Ola [1 ,2 ]
Noren, G. Niklas [1 ]
Ekenberg, Love [2 ]
Edwards, I. Ralph [1 ]
机构：
[1] WHO Collaborating Ctr Int Drug Monitoring, Uppsala, Sweden
[2] Stockholm Univ, Dept Comp & Syst Sci, Stockholm, Sweden
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
17
引用
下载
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [41] Model-Based Benefit-Risk Assessment: Can Archimedes Help?
    Krishna, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (03) : 239 - 240
  • [42] Benefit-Risk Assessment of Zaleplon in the Treatment of Insomnia
    Joseph Barbera
    Colin Shapiro
    Drug Safety, 2005, 28 : 301 - 318
  • [43] Benefit-Risk Assessment of Antileukotrienes in the Management of Asthma
    Luis García-Marcos
    Antje Schuster
    Eduardo G. Pérez-Yarza
    Drug Safety, 2003, 26 : 483 - 518
  • [44] Interactive dashboards for vaccine benefit-risk assessment
    Reactions Weekly, 2018, 1696 (1) : 8 - 8
  • [45] Benefit-Risk Assessment of Diacerein in the Treatment of Osteoarthritis
    Panova, Elena
    Jones, Graeme
    DRUG SAFETY, 2015, 38 (03) : 245 - 252
  • [46] Incorporation of a Benefit-Risk Assessment Framework Into the Clinical Overview of Marketing Authorization Applications
    Wolka, Anne
    Warner, Margaret
    Bullok, Kristin
    Wang, JuAn
    Radawski, Christine
    Noel, Rebecca
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (01) : 130 - 134
  • [47] A Counterfactual P-Value Approach for Benefit-Risk Assessment in Clinical Trials
    Zeng, Donglin
    Chen, Ming-Hui
    Ibrahim, Joseph G.
    Wei, Rachel
    Ding, Beiying
    Ke, Chunlei
    Jiang, Qi
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2015, 25 (03) : 508 - 524
  • [48] Incorporation of a Benefit-Risk Assessment Framework Into the Clinical Overview of Marketing Authorization Applications
    Anne Wolka
    Margaret Warner
    Kristin Bullok
    JuAn Wang
    Christine Radawski
    Rebecca Noel
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 130 - 134
  • [49] The Benefit Risk Assessment of Consumption of Marine Species Based on Benefit-Risk Analysis for Foods (BRAFO)-tiered Approach
    Gao Yi Xiong
    Zhang Hong Xia
    Li Jing Guang
    Zhang Lei
    Yu Xin Wei
    He Jia Lu
    Shang Xiao Hong
    Zhao Yun Feng
    Wu Yong Ning
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2015, 28 (04) : 243 - 252
  • [50] The Benefit Risk Assessment of Consumption of Marine Species Based on Benefit-Risk Analysis for Foods(BRAFO)-tiered Approach
    GAO Yi Xiong
    ZHANG Hong Xia
    LI Jing Guang
    ZHANG Lei
    YU Xin Wei
    HE Jia Lu
    SHANG Xiao Hong
    ZHAO Yun Feng
    WU Yong Ning
    Biomedical and Environmental Sciences, 2015, 28 (04) : 243 - 252
12345